There are 2789 resources available
1112P - Modified TGR: A new strong radiological marker to accurately predict early response to PRRT in GEPNETs
Presenter: Federica Scalorbi
Session: ePoster Display
1113P - Care for neuroendocrine tumor patients, monitored by medical oncologists: Comparative data Europe vs North America
Presenter: Teodora Kolarova
Session: ePoster Display
1035TiP - A phase I/Ib study of MPT-0118 as monotherapy and in combination with pembrolizumab in subjects with advanced or metastatic solid tumors
Presenter: David Sommerhalder
Session: ePoster Display
Resources:
Abstract
1042P - Anti-PD1 (PD1) monotherapy or in combination with ipilimumab (IPI) after BRAF/MEK inhibitors (BRAF/MEKi) in BRAF mutant metastatic melanoma (MM) patients (pts)
Presenter: Ines Pires da Silva
Session: ePoster Display
1043P - NF1 mutations and immune checkpoint inhibitor outcomes in patients with BRAF wildtype melanoma
Presenter: Maysa Vilbert
Session: ePoster Display
1044P - Sequential targeted and immunotherapies in stage IV melanoma
Presenter: Teresa Amaral
Session: ePoster Display
1045P - Comparison between first-line target therapy and immunotherapy in different prognostic categories of BRAF mutant metastatic melanoma patients
Presenter: Riccardo Marconcini
Session: ePoster Display
1046P - First-line anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy in Japanese mucosal melanoma: A retrospective, multicenter study (JMAC study)
Presenter: Yasuhiro Nakamura
Session: ePoster Display
1074P - Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile
Presenter: Michele Del Vecchio
Session: ePoster Display